Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitors

Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitors

US Patent 7678784 · Granted Mar 16, 2010

Estimated economic value: $82,660,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Janus kinase (JAK) family inhibitor, preparation of same, and applications there2025
Silicon nitride ceramic heating and ignition device for granular fuel barbecue o2025
Triazolopyridinyl compounds as kinase inhibitors2024
Heating ignition device2024
Pyridinylaminopyrimidine derivatives, preparation process and use thereof2024
Triazolopyridinyl compounds as kinase inhibitors2023
Test strip for milk immunofluorescence assay (IFA) and use thereof2023
Aminopyrrolotriazines as kinase inhibitors2023
Tropomyosin receptor kinase inhibitor, preparation method therefor and use there2023
Pyridinylaminopyrimidine derivatives, preparation process and use thereof2021
MCT4 inhibitors and uses thereof2021
Acyl sulfonamide NaV1.7 inhibitors2020